Stock Information
Denali Therapeutics Inc (DNLI)
Ticker Symbol: DNLI
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $3,117.91 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -2.969
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -50.13%
Latest News
-
Denali Therapeutics Signs Deal To Sell Its Rare Pediatric Disease Priority Review Voucher For $195M
Thu, Jun 18, 2026 8:07 AM
Key Financials
Financial data not available